Login

Carisma Therapeutics Inc. 4 SEC Filings

Filed On Filing
08 Oct 2025 Form 4: Klichinsky Michael, Chief Scientific Officer

Received 56,982 shares by exercise or conversion ($6.27K) · Sold 56,982 shares ($14.5K)

03 Oct 2025 Form 4: Klichinsky Michael, Chief Scientific Officer

Sold 165,000 shares ($42.4K) · Sold 200,000 shares ($50.9K) · Sold 119,347 shares ($31.1K)

30 Jan 2025 Form 4: Klichinsky Michael, Chief Scientific Officer

Granted 221,000 Stock Option (Right to Buy)

30 Jan 2025 Form 4: Kelly Steven, Director

Granted 500,000 Stock Option (Right to Buy)

01 Nov 2024 Form 4: Cheng Sohanya Roshan, Director

Granted 38,700 Stock Option (Right to Buy)

01 Jul 2024 Form 4: Thorell Marella, Director

Granted 38,700 Stock Option (Right to Buy)

01 Jul 2024 Form 4: Scadden David, Director

Granted 38,700 Stock Option (Right to Buy)

27 Jun 2024 Form 4: Zweifach Sanford S, Director

Granted 19,350 Stock Option (Right to Buy)

27 Jun 2024 Form 4: Morrison Briggs, Director

Granted 19,350 Stock Option (Right to Buy)

27 Jun 2024 Form 4: Hohneker John, Director

Granted 19,350 Stock Option (Right to Buy)

27 Jun 2024 Form 4: Torok Michael, Director

Granted 19,350 Stock Option (Right to Buy)

18 Jun 2024 Form 4: Morris Richard Steven, Chief Financial Officer

Granted 85,000 Stock Option (Right to Buy)

18 Jun 2024 Form 4: Klichinsky Michael, Chief Scientific Officer

Granted 85,000 Stock Option (Right to Buy)

18 Jun 2024 Form 4: Kelly Steven, Director

Granted 125,000 Stock Option (Right to Buy)

01 Apr 2024 Form 4: Hohneker John, Director

Granted 38,700 Stock Option (Right to Buy)

02 Feb 2024 Form 4: Morris Richard Steven, Chief Financial Officer

Granted 170,500 Stock Option (Right to Buy)

02 Feb 2024 Form 4: Klichinsky Michael, Chief Scientific Officer

Granted 170,500 Stock Option (Right to Buy)

02 Feb 2024 Form 4: Kelly Steven, Director

Granted 438,000 Stock Option (Right to Buy)

08 Jun 2023 Form 4: Kelly Steven, Director

Granted 600,000 Stock Option (Right to Buy)

08 Jun 2023 Form 4: Zweifach Sanford S, Director

Granted 38,700 Stock Option (Right to Buy)

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support